LINDIS Biotech’s Korjuny Approved by European Commission for Malignant Ascites
Germany-based LINDIS Biotech GmbH announced that it has received market approval from the European Commission...
LINDIS Biotech
LINDIS Biotech’s Catumaxomab Receives Positive Opinion from EMA’s COMP for Malignant Ascites Treatment
LINDIS Biotech GmbH, a German biotechnology company, has announced that the Committee for Orphan Medicinal...